Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Verona Pharma Plc ADR
(NQ:
VRNA
)
13.00
-0.36 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Verona Pharma Plc ADR
< Previous
1
2
3
4
Next >
Verona Pharma Stock Garners Investors' Attention After Successful COPD Trial
December 20, 2022
Via
Benzinga
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More
December 20, 2022
Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 20, 2022
Via
Benzinga
Lucid Group, Verona Pharma And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 20, 2022
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday
December 20, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
Short Volatility Alert: Verona Pharma plc
September 22, 2022
On Wednesday, shares of Verona Pharma plc (NASDAQ: VRNA) experienced volatile short activity. After the activity, the stock price went down -0.90% to $9.96. The overall sentiment for VRNA has been...
Via
Benzinga
HC Wainwright Raises Price For This Lung Disease Stock On First Pivotal Readout
August 29, 2022
Via
Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small...
Via
Benzinga
Why You Should Invest Microcap Stocks
November 25, 2022
There’s a misperception in the market that low-priced stocks can move faster than high-priced stocks.
Via
Talk Markets
Earnings Scheduled For November 9, 2022
November 09, 2022
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
Via
Benzinga
Recap: Verona Pharma Q2 Earnings
August 09, 2022
Verona Pharma (NASDAQ:VRNA) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Is Verona Pharma (VRNA) Stock Up 76% Today?
August 09, 2022
Verona Pharma (VRNA) stock is rocketing higher on Tuesday following the release of its latest earnings report and clinical trial results.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
US Stock Futures Signal Higher Start On Wall Street; Bank of America Earnings In Focus
October 17, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Monday after closing lower in the previous session. The Dow Jones dropped by more than 400 points in the previous session,...
Via
Benzinga
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
September 19, 2022
The biotech run off a June bottom is great — until you realize you could've netted more.
Via
Investor's Business Daily
Ulta Beauty To $511? Here Are 5 Other Price Target Changes For Monday
August 29, 2022
Barclays boosted the price target on Ulta Beauty, Inc. (NASDAQ: ULTA) from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022
August 26, 2022
Upgrades
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 19, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
Via
Benzinga
Dow Drops Over 100 Points; Verona Pharma Shares Jump
August 09, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 09, 2022
Via
Benzinga
Nasdaq Eyes Triple-Digit Drop, 3rd-Straight Daily Loss
August 09, 2022
Stocks are struggling midday, with the Dow Jones Industrial Average briefly clawing back above its breakeven mark before falling to a 47-point drop, while the S&P 500 Index also sits in the red.
Via
Talk Markets
Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher
August 09, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
August 09, 2022
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The...
Via
Benzinga
Why Is Norwegian Cruise (NCLH) Stock Down 12% Today?
August 09, 2022
Norwegian Cruise (NCLH) stock is sinking on Tuesday as investors react to the company's earnings report for the second quarter of 2022.
Via
InvestorPlace
Tuesday Morning (TUEM) Stock Rockets 32% Amid Bankruptcy Talk
August 09, 2022
Tuesday Morning (TUEM) stock is soaring higher today as investors boost the shares amid talk of a potential bankruptcy filing.
Via
InvestorPlace
Clover Health (CLOV) Stock Sinks on Leadership Change Announcement
August 09, 2022
Clover Health (CLOV) stock is falling on Tuesday after the company announced changes are coming to its leadership team alongside Q2 earnings.
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.